Neurovascular Diagnostics
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$4.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neurovascular Diagnostics is a biotechnology company developing a blood-based diagnostic assay for the early detection and risk profiling of unruptured intracranial aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurovascular Diagnostics Comparables
Compare Neurovascular Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astria Biosciences, Inc. | 90% | |
| MultiplAI Health | 71% | |
| Ischemia Care | 71% |
Neurovascular Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Grant | Jan 11, 2024 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Nov 6, 2019 | ||||
| Grant | Feb 4, 2018 | ||||
Grant | Feb 4, 2018 |
Neurovascular Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| University at Buffalo Center for Advanced Technology in Big Data and Health Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 95% MoM.
- May 18, 2026
Monthly visitors increased 1857% to 920.
Neurovascular Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurovascular Diagnostics's valuation, stock price, and market status.
Is Neurovascular Diagnostics a public or private company?
Neurovascular Diagnostics is a private company.
What is the current stock price of Neurovascular Diagnostics?
Neurovascular Diagnostics is a private company with no public stock price. Caplight tracks Neurovascular Diagnostics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Neurovascular Diagnostics worth (valuation)?
Valuation information for Neurovascular Diagnostics is not publicly available.
Can I buy Neurovascular Diagnostics stock?
Neurovascular Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurovascular Diagnostics's last funding round?
Neurovascular Diagnostics's most recent funding round was Grant on September 24, 2024.
Who are the main investors in Neurovascular Diagnostics?
Key investors in Neurovascular Diagnostics include National Institutes of Health (NIH), University at Buffalo Center for Advanced Technology in Big Data and Health Sciences, National Science Foundation.
Will Neurovascular Diagnostics IPO soon?
No public IPO plans have been announced for Neurovascular Diagnostics.
How can I track Neurovascular Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurovascular Diagnostics's secondary market activity and sign up for updates.